Suppr超能文献

肾实质疾病高血压患者的尿激肽释放酶活性

Urinary kallikrein activity in the hypertension of renal parenchymal disease.

作者信息

Mitas J A, Levy S B, Holle R, Frigon R P, Stone R A

出版信息

N Engl J Med. 1978 Jul 27;299(4):162-5. doi: 10.1056/NEJM197807272990402.

Abstract

To learn more about the regulation of blood pressure in renal parenchymal disease, 57 subjects (18 normal controls, 25 patients with essential hypertension and 14 with renal parenchymal disease and hypertension) were evaluated for peripheral renin activity, 24-hour urinary kallikrein activity and whole-blood volume. Blood volumes were significantly lower in patients with essential hypertension (P less than 0.001) and those with renal disease and hypertension (P less than 0.001) than in normotensive subjects. Renin activities (measured after the subjects were standing) were also lower in patients with essential hypertension and hypertension due to renal disease (P less than 0.01 and P less than 0.02, respectively). Kallikrein activity was similar in subjects with renal disease and those with hypertension (P less than 0.05) but markedly diminished in both groups as compared with normotensive subjects (P less than 0.001 and P less than 0.01, respectively) when glomerular filtration rates were taken into account. The kallikrein-kinin system may be involved in the hypertension associated with renal parenchymal disease.

摘要

为了更深入了解肾实质性疾病中血压的调节情况,对57名受试者(18名正常对照者、25名原发性高血压患者以及14名肾实质性疾病合并高血压患者)进行了外周肾素活性、24小时尿激肽释放酶活性及全血容量的评估。原发性高血压患者以及肾疾病合并高血压患者的血容量显著低于血压正常的受试者(P<0.001)。原发性高血压患者以及肾疾病所致高血压患者站立后测得的肾素活性也较低(分别为P<0.01和P<0.02)。肾疾病患者与高血压患者的激肽释放酶活性相似(P<0.05),但在考虑肾小球滤过率时,与血压正常的受试者相比,两组患者的激肽释放酶活性均显著降低(分别为P<0.001和P<0.01)。激肽释放酶-激肽系统可能与肾实质性疾病相关的高血压有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验